Orencia
The Top Pharma List rankings are compiled from GlobalData’s pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. Listed below are the charts and positions for Orencia in this year’s pharmaceutical sales data alongside recent articles on PMLiVE featuring Orencia.
44
Global Revenue Ranking
Recent articles on PMLiVE featuring Orencia
The company will provide Eliquis, its oral blood thinner, free of charge to Medicaid
Bristol Myers Squibb’s arthritis drug, Orencia, can now be given to adults and children undergoing stem cell transplants to prevent the life-threatening condition
Leukaemia patients who receive stem cell transplant may gain access to Orencia by the end of the year
Group sales rose 6% to $6bn in the third quarter
And AZ claims first with Forxiga in T1 diabetes
Sales beginning to lose momentum despite new indications bringing in $1.3bn for Q4
Plans to invest in biologics production with potential divestment of older brands
Will fund programme for another 12 months while divesting ongoing activities to Momenta
Shire, Roche, Sanofi, BMS and Merck & Co are among those featured in this month’s roundup of M&A and other pharma deal activity
Deal with Momenta bolsters biosimilars pipeline for new products
Pledgesto continue anacetrapib trials despite series of failures in its class
Includes BMS’ Orencia and AbbVie’s Humira
Data provided by GlobalData
GlobalData provides trusted intelligence on the world’s largest industries including Pharmaceutical and Medical Devices. With over 2,000 in-house experts, our data-driven, technology-powered approach delivers gold-standard insights to help businesses navigate complex markets and predict future trends.
Our integrated platform empowers 4,000 of the world’s largest companies—including over 70% of FTSE 100 and 60% of Fortune 100 firms—to make timely, informed decisions through unique data, expert analysis, and innovative consulting solutions.
To find out more about how our research and insights can help you, please visit https://www.globaldata.com/who-we-are/why-globaldata/
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE’s Top Pharma List – Methodology